Updated:
KWS
KWS is an SEC-registered investment adviser in EDINBURG, TX. The firm manages approximately $9 million in regulatory assets. It has 1 employee and 1 investment...
KWS
KWS is an SEC-registered investment adviser in EDINBURG, TX. The firm manages approximately $9 million in regulatory assets. It has 1 employee and 1 investment adviser.
General information
Firm type
Corporate Investor
Year founded
1856
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Einbeck
Corporate office
Grimsehlstr. 31, 37555 Einbeck, Germany
Additional offices
St. Louis, Missouri, USA
Principals
Dr. Felix Büchting
CEO
Andreas J. Büchting
Supervisory Board Member
Dr. Marie Schnell
Supervisory Board Member
Sector focus
Frequently asked questions
Who controls KWS, and how is governance structured?
KWS is controlled by the Büchting family, with Dr. Felix Büchting as CEO and Andreas J. Büchting serving on the Supervisory Board. Two additional family shareholders — the Tessner family via Tessner Beteiligungs GmbH (owning 15.4%) and the Arend Oetker family, represented by Dr. Marie Schnell — hold significant minority stakes. This multi-family, concentrated ownership structure embeds a patient-capital ethos into a publicly listed entity.
How does KWS allocate capital as an investor?
KWS does not operate as a conventional institutional allocator with an external portfolio. Its capital deployment is almost entirely operational: it invests roughly 19% of annual revenue into plant breeding research and development, maintains gene banks, builds breeding stations, and acquires or divests business lines — such as the January 2024 sale of its South American corn business to GDM. Intellectual property and germplasm are its primary stores of long-term asset value.
What is the significance of KWS's R&D-to-revenue ratio?
KWS's R&D expenditure, typically around 19% of annual revenue, is among the highest in listed agribusiness globally. This investment intensity functions as a multi-decade capital allocation program — breeding a new sugarbeet variety can take 10–15 years from initial cross to commercial release. The family-controlled governance structure enables this time-horizon discipline without quarterly earnings pressure overriding long-cycle biological programs.
What is KWS's relationship with Limagrain?
KWS and Limagrain, a French farmer-owned seed cooperative, are long-term joint-venture partners in AgReliant Genetics, a North American field-crop breeding company headquartered in Westfield, Indiana. The partnership gives KWS direct exposure to the US Corn Belt's seed market alongside one of Europe's other major independent breeders, combining germplasm pools and R&D resources without full consolidation.
Does KWS maintain philanthropic or non-commercial investment structures?
Yes. KWS is associated with the AKB Stiftung and the Zukunftsstiftung Jugend, Umwelt und Kultur, foundations focused on youth, environmental, and cultural initiatives around its home region of Einbeck, Germany. Additionally, the firm maintains the KWS Art Collection and an exhibition space called Kunst im BiT at its Biotechnikum campus, reflecting a multi-generational family tradition of cultural patronage separate from the commercial seed business.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: